Literature DB >> 27633143

Association between age and overall survival of patients with hepatocellular carcinoma after hepatic resection.

Jun-Tao Tan1, Chang Zhao1, Ning-Fu Peng1, Yang Yang2, Jian-Hong Zhong1, Tian Yang3, Ming-Hua Zheng4, Yan-Yan Wang1, Wen-Feng Gong1, Bang-De Xiang1, Le-Qun Li1.   

Abstract

AIM: The suitability of hepatic resection for older patients remains controversial. This study aimed to investigate whether age influences overall survival of patients with hepatocellular carcinoma (HCC) after resection.
METHODS: Records of 1,132 patients with HCC after hepatic resection were retrospectively reviewed. Overall survival (OS) was compared between younger and older patients based on five cut-off ages (30, 40, 50, 60, and 70 years).
RESULTS: Across all patients, OS was 89.7% at 1 year, 67.7% at 3 years, and 47.7% at 5 years. OS was similar between younger and older patients at all cut-off ages (all P > 0.1), but OS was marginally lower among patients >70 years old than those ≤70 (P = 0.090). Multivariate analyses identified several risk factors for lower OS: preoperative serum albumin <35 g/L, alanine aminotransferase >80 U/L, α-fetoprotein ≥400 ng/ml, presence of esophagogastric varices or macrovascular invasion, incomplete/absent tumor capsule, tumor size >10 cm, tumor number ≥3, and major hepatectomy.
CONCLUSION: Age does not influence the prognosis of patients with HCC after hepatic resection. Older patients should be considered for curative resection if remnant liver volume and liver function are adequate. J. Surg. Oncol. 2016;114:966-970.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  age; hepatic resection; hepatocellular carcinoma; overall survival

Mesh:

Year:  2016        PMID: 27633143     DOI: 10.1002/jso.24434

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  8 in total

1.  A Predictive Nomogram of Early Recurrence for Patients with AFP-Negative Hepatocellular Carcinoma Underwent Curative Resection.

Authors:  Wencui Li; Lizhu Han; Bohan Xiao; Xubin Li; Zhaoxiang Ye
Journal:  Diagnostics (Basel)       Date:  2022-04-25

2.  Hepatocellular carcinoma in old age: are there any benefits of liver resection in old age?

Authors:  In Sik Shin; Deok Gie Kim; Sung Whan Cha; Seong Hee Kang; Sung Hoon Kim; Moon Young Kim; Soon Koo Baik
Journal:  Ann Surg Treat Res       Date:  2020-07-31       Impact factor: 1.859

Review 3.  Controversies and evidence of hepatic resection for hepatocellular carcinoma.

Authors:  Jian-Hong Zhong; Guido Torzilli; Hao Xing; Chao Li; Jun Han; Lei Liang; Han Zhang; Shu-Yang Dai; Le-Qun Li; Feng Shen; Tian Yang
Journal:  BBA Clin       Date:  2016-10-11

4.  Tumor stage and primary treatment of hepatocellular carcinoma at a large tertiary hospital in China: A real-world study.

Authors:  Jian-Hong Zhong; Ning-Fu Peng; Xue-Mei You; Liang Ma; Xiao Xiang; Yan-Yan Wang; Wen-Feng Gong; Fei-Xiang Wu; Bang-De Xiang; Le-Qun Li
Journal:  Oncotarget       Date:  2017-03-14

5.  Development of a preoperative prognostic scoring system to predict benefits of hepatic resection in advanced hepatocellular carcinoma patients.

Authors:  Chang-Zhi Chen; Jian-Hong Zhong; Ya-Peng Qi; Jie Zhang; Tao Huang; Liang Ma; Le-Qun Li; Tao Peng; Bang-De Xiang
Journal:  Biosci Rep       Date:  2021-04-30       Impact factor: 3.840

6.  Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival.

Authors:  Lidi Ma; Kan Deng; Cheng Zhang; Haixia Li; Yingwei Luo; Yingsi Yang; Congrui Li; Xinming Li; Zhijun Geng; Chuanmiao Xie
Journal:  Front Oncol       Date:  2022-02-28       Impact factor: 6.244

7.  Identification of a novel DNA repair-related prognostic signature predicting survival of patients with hepatocellular carcinoma.

Authors:  Na Li; Lan Zhao; Chunyan Guo; Chang Liu; Yongyu Liu
Journal:  Cancer Manag Res       Date:  2019-08-06       Impact factor: 3.989

8.  Prognostic Role of Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Level in Early Stage Hepatocellular Carcinoma.

Authors:  Joseph Lin; Chih-Jan Ko; Yu-Ju Hung; Ping-Yi Lin; Kuo-Hua Lin; Chia-En Hsieh; Chen-Te Chou; Yao-Li Chen
Journal:  Sci Rep       Date:  2020-03-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.